We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Transgenic System for Soil Remediation

By Biotechdaily staff writers
Posted on 29 Oct 2002
Researchers have developed the first transgenic system for removing arsenic from the soil by using genetically modified plants. More...
Their work was reported in the October 6, 2002, issue of Nature Biotechnology.

The researchers inserted two genes from the common bacterium Escherichia coli that allow a member of the mustard family called Arabidopsis to tolerate arsenic, usually lethal to plants. Arabidopsis can then remove arsenic from the soil and transport it to the plant's leaves in a form that is far less biologically available in the environment. When the healthy plants are harvested, much of the arsenic pollution, once in the soil, can be removed from the site. In tests, 96-100% of arsenic in leaves was reduced to arsenite and bound by sulphur, making the system highly effective.

Arsenic contamination is an enormous worldwide problem. The new strategy, called phytoredmediation, cleans polluted soil through the use of plants that sequester poisons and make them less harmful.

"Our data demonstrate the first significant increase in arsenic tolerance and what we call ‘hyperaccumulation' by genetically engineered plants,” said Dr. Richard Meagher, of the University of Georgia (Athens, USA; www.uga.edu) and one of the researchers.





Related Links:
University of Georgia

Gold Member
Blood Gas Analyzer
Stat Profile pHOx
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gram-Negative Blood Culture Assay
LIAISON PLEX Gram-Negative Blood Culture Assay
Gel Cards
DG Gel Cards
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Industry experts gather at WHX Labs Dubai to discuss how leadership must adapt as AI and automation transform the laboratory (Photo courtesy of Shutterstock)

WHX Labs in Dubai spotlights leadership skills shaping next-generation laboratories

WHX Labs in Dubai (formerly Medlab Middle East), held at Dubai World Trade Centre (DWTC) from 10–13 February, brings together international experts to discuss the factors redefining laboratory leadership,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.